SNHG18 and central nervous system cancer: To determine whether SNHG18 participates in glioma progression by adsorbing miR-338-5p, we co-transfected si-SNHG18#1+ miR-338-5p inhibitors into U251 and T98G cells, and qRT-PCR validated the successful transfection (Figure 4(a)).